港股异动|內险股普涨中国人保升逾4%领涨
格隆汇7月19日丨內险股普涨。中国人保(1339.HK)升逾4%领涨,众安在线、新华保险涨逾2%,中国人寿、中国平安等涨逾1%。近日,A股5大上市险企上半年保费成绩悉数出炉,中国人保、中国人寿、中国平安、中国太保、新华保险5家险企共揽获保费14268.41亿元,同比增长8.77%。交银国际预计,上半年投资收益同比有所增长;保险公司手续费支出税前抵扣比例提升,2018年少缴的所得税有望全部或部分计入上半年盈利;预计上半年保险公司盈利增长将较为强劲。维持行业“领先”评级,维持平安、太保、国寿和中国财险的“买入”评级。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.